Used in targeted cancer therapies, particularly for prostate cancer, due to its specific binding to folate hydrolase 1 (PSMA), which is overexpressed on prostate cancer cells. Enables precise delivery of therapeutic agents or imaging molecules, enhancing treatment efficacy and diagnostic accuracy. Employed in antibody-drug conjugates and radiolabeled imaging for PET scans. Supports monitoring disease progression and response to therapy.